NM_006063.3:c.197T>C

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS1

The NM_006063.3(KLHL41):​c.197T>C​(p.Ile66Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000484 in 1,614,112 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00039 ( 1 hom. )

Consequence

KLHL41
NM_006063.3 missense

Scores

2
16

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 6.49

Publications

3 publications found
Variant links:
Genes affected
KLHL41 (HGNC:16905): (kelch like family member 41) This gene is a member of the kelch-like family. The encoded protein contains a BACK domain, a BTB/POZ domain, and 5 Kelch repeats. This protein is thought to function in skeletal muscle development and maintenance. Mutations in this gene have been associated with nemaline myopathy (NM), a rare congenital muscle disorder. [provided by RefSeq, Mar 2015]
KLHL41 Gene-Disease associations (from GenCC):
  • nemaline myopathy 9
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • childhood-onset nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • intermediate nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • typical nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • severe congenital nemaline myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0035518706).
BP6
Variant 2-169509975-T-C is Benign according to our data. Variant chr2-169509975-T-C is described in ClinVar as Likely_benign. ClinVar VariationId is 474869.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00134 (204/152250) while in subpopulation AFR AF = 0.00334 (139/41562). AF 95% confidence interval is 0.00289. There are 0 homozygotes in GnomAd4. There are 93 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KLHL41NM_006063.3 linkc.197T>C p.Ile66Thr missense_variant Exon 1 of 6 ENST00000284669.2 NP_006054.2 O60662-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KLHL41ENST00000284669.2 linkc.197T>C p.Ile66Thr missense_variant Exon 1 of 6 1 NM_006063.3 ENSP00000284669.1 O60662-1
ENSG00000251569ENST00000513963.1 linkc.925-4599T>C intron_variant Intron 11 of 15 2 ENSP00000424363.1 E9PBE3

Frequencies

GnomAD3 genomes
AF:
0.00133
AC:
203
AN:
152132
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00333
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000786
Gnomad ASJ
AF:
0.00980
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.000855
AC:
215
AN:
251418
AF XY:
0.000736
show subpopulations
Gnomad AFR exome
AF:
0.00375
Gnomad AMR exome
AF:
0.00122
Gnomad ASJ exome
AF:
0.00813
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000220
Gnomad OTH exome
AF:
0.000652
GnomAD4 exome
AF:
0.000395
AC:
577
AN:
1461862
Hom.:
1
Cov.:
32
AF XY:
0.000378
AC XY:
275
AN XY:
727228
show subpopulations
African (AFR)
AF:
0.00278
AC:
93
AN:
33474
American (AMR)
AF:
0.00123
AC:
55
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00853
AC:
223
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00208
AC:
12
AN:
5768
European-Non Finnish (NFE)
AF:
0.000108
AC:
120
AN:
1111994
Other (OTH)
AF:
0.00118
AC:
71
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
39
78
118
157
196
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00134
AC:
204
AN:
152250
Hom.:
0
Cov.:
32
AF XY:
0.00125
AC XY:
93
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.00334
AC:
139
AN:
41562
American (AMR)
AF:
0.000785
AC:
12
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00980
AC:
34
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4816
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
68014
Other (OTH)
AF:
0.00284
AC:
6
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
10
20
29
39
49
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000915
Hom.:
1
Bravo
AF:
0.00155
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00340
AC:
15
ESP6500EA
AF:
0.000581
AC:
5
ExAC
AF:
0.000832
AC:
101
EpiCase
AF:
0.000600
EpiControl
AF:
0.000296

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

KLHL41-related disorder Benign:1
Jun 28, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Apr 19, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nemaline myopathy 9 Benign:1
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.054
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.33
CADD
Benign
20
DANN
Benign
0.86
DEOGEN2
Benign
0.16
T
Eigen
Benign
-0.13
Eigen_PC
Benign
0.087
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Benign
0.83
T
MetaRNN
Benign
0.0036
T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
-0.34
N
PhyloP100
6.5
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
-1.7
N
REVEL
Benign
0.12
Sift
Benign
0.57
T
Sift4G
Benign
0.40
T
Polyphen
0.010
B
Vest4
0.30
MVP
0.80
MPC
0.38
ClinPred
0.021
T
GERP RS
5.2
PromoterAI
0.046
Neutral
Varity_R
0.097
gMVP
0.50
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs116809051; hg19: chr2-170366485; API